Georgetown University home page Search: Full text search Site Index: Find a web site by name or keyword Site Map: Overview of main pages Directory: Find a person; contact us About this site: Copyright, disclaimer, policies, terms of use Georgetown University home page Home page for prospective students Home page for current students Home page for alumni and alumnae Home page for family and friends Home page for faculty and staff Georgetown University Search: Full text search Site Index: Find a web site by name or keyword Site Map: Overview of main pages Directory: Find a person; contact us About this site: Copyright, disclaimer, policies, terms of use
Navigation bar Navigation bar
spacer spacer spacer spacer
spacer spacer spacer
spacer spacer



Karen Mallet (media only)

Lombardi Lymphoma Expert Elected Chairman of Lymphoma Research Foundation's Scientific Advisory Board

Washington, DCBruce D. Cheson, MD, Head of Hematology and Director of Hematology Research at the Lombardi Comprehensive Cancer Center of Georgetown University Medical Center assumes the role as chairman of the Lymphoma Research Foundation’s Scientific Advisory Board (SAB). Cheson’s two-year term began this month.

“We are pleased to have Dr. Cheson take on this important role,” says LRF chief executive officer Diane Blum, MSW. “He has generously given of his time to the Foundation for many years, holding a variety of leadership roles and bringing a wealth of experience to the position. He is a visionary leader, and his insight and skills will prove invaluable.”

Comprised of the world’s leading lymphoma researchers and oncologists, the SAB formulates the Foundation’s research portfolio, seeking out the most innovative and promising lymphoma research projects for support. The 40-member SAB reviews grant proposals and makes recommendations regarding research priorities and funding to the LRF board of directors. The SAB also evaluates the progress of on-going research projects and guides the strategic direction of the Foundation’s research programs and consortia. Cheson has been a member of the SAB since 2001.

”I am honored to be elected to chair the SAB,” says Cheson. “The Lymphoma Research Foundation helps to support critical research in a family of serious blood disorders. Its commitment to patients, caregivers, and medical professionals makes the Foundation an effective advocate for the thousands who are burdened with this disease.”

Cheson's clinical interests focus on the development and evaluation of new therapeutic approaches for hematologic malignancies. He has more than 300 publications with his expertise in both clinical and research medicine. A graduate of the University of Virginia and Tufts University Medical School, he completed his internship and residency in Internal Medicine at the University of Virginia Hospitals and his clinical and research fellowship in Hematology at New England Medical Center Hospital.

Cheson is a renowned member of numerous editorial boards. He is an Editor-in-Chief of Clinical Lymphoma, Myeloma & Leukemia, and Clinical Advances in Hematology & Oncology. He is associate editor of Oncology, and Oncology News International. Cheson served as associate editor of the Journal of Clinical Oncology. He currently chairs the Lymphoma Committee of the Cancer and Leukemia Group B (CALGB), a National Cancer Institute-supported clinical trial cooperative group, and is co-chair of the International Harmonization Project in Lymphoma, an international team of cancer specialists and imaging experts, and the American Joint Committee on Cancer Subcommittee on Lymphoma.

The Lymphoma Research Foundation (LRF) is the nation's largest non-profit lymphoma organization devoted to funding innovative research and providing people with lymphoma and healthcare professionals with critical information on the disease. To date, LRF has funded over $40 million in lymphoma-specific research. For additional information on LRF’s programs and services, visit

About Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to

About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.


spacer spacer
Navigation bar Navigation bar